Sort
85,873 grants matching “alzheimers”
A Pilot CSF Catheter Study to Evaluate the Effect of CT1812 Treatment on Aβ Oligomer Clearance into CSF in Subjects with Mild to Moderate Alzheimerʼs Disease
$2,527,271Susan M Catalano · Cognition Therapeutics, Inc. · RF1 · FY2017 · AG
RNA-binding Factors Implicated in Neurogenesis, Alzheimer's Disease, and other Neurodegenerative Pathologies
$2,527,182Myriam Gorospe · National Institute On Aging · ZIA · FY2020 · AG
EPIDEMIOLOGY OF DEMENTIA IN AN URBAN COMMUNITY
$2,524,865Columbia University Health Sciences · P01 · FY2000 · AG
Discovery of Chemical Probes and Therapeutic Leads
$2,523,825Joseph M Fox · University Of Delaware · P20 · FY2014 · GM
Functional Genomics and Bioinformatics Data management Core
$2,523,353Seyed Ali Mortazavi · University Of California-Irvine · U54 · FY2025 · AG
Computational and Circuit Mechanisms Underlying Rapid Learning
$2,523,348Elizabeth A Buffalo · University Of Washington · U19 · FY2021 · NS
A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects
$2,522,029Douglas R Galasko · University Of California, San Diego · R01 · FY2022 · AG
Neurobiology of Mild Cognitive Impairment in the Elderly
$2,521,865Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · P01 · FY2020 · AG
Genetic Epidemiological Studies of Alzheimer Disease
$2,520,781Lindsay A. Farrer · Boston University Medical Campus · R01 · FY2006 · AG
Genomic regulation of immune response in neurodegeneration in mice
$2,520,048Han-Yu Shih · National Eye Institute · ZIA · FY2025 · EY
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems
$2,518,235Vincent Mor · Brown University · P01 · FY2019 · AG
Development of on-chip ultra high-throughput whole-animal assay technologies
$2,517,500Mehmet Fatih Yanik · Massachusetts Institute Of Technology · DP2 · FY2007 · OD
Neuronal activity-responsive DNA repair mechanisms and cognitive aging
$2,516,316Michael E Greenberg · Harvard Medical School · RF1 · FY2024 · AG
Clinical Core
$2,516,114Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2024 · AG
Toward Personalized Prognosis and Outcomes in Primary Progressive Aphasia
$2,515,977Bradford C Dickerson · Massachusetts General Hospital · RF1 · FY2023 · NS
Single-cell Mapping Center for Human Regulatory Elements and Gene Activity
$2,515,744Ansuman Satpathy · Stanford University · UM1 · FY2025 · HG
Single-cell Mapping Center for Human Regulatory Elements and Gene Activity
$2,515,742Ansuman Satpathy · Stanford University · UM1 · FY2024 · HG
Impact of Neuroinflammation on AD Occurrence: A Bi-Generational Population Study
$2,514,901Kumar B. Rajan · Rush University Medical Center · R01 · FY2025 · AG
RNA dynamics and co-translational decay in aging and aging-related disease
$2,514,773Emmanouil Maragkakis · National Institute On Aging · ZIA · FY2022 · AG
Changing the Trajectory of Mild Cognitive Impairment with CPAP Treatment of Obstructive Sleep Apnea
$2,514,739Nalaka S Gooneratne · University Of Pennsylvania · R01 · FY2017 · AG
Age-related changes of cognition in health and disease
$2,512,745Massachusetts General Hospital · P01 · FY2003 · AG
Alzheimer's Disease Research Center
$2,512,624John Morris · Washington University · P50 · FY2008 · AG
Elucidating the Role of a Novel Family of Chemoreceptor in Alzheimer's Disease
$2,512,500Paul Lieberman Greer · Univ Of Massachusetts Med Sch Worcester · DP2 · FY2019 · AG
Investigating the molecular basis of risk and resilience to Alzheimer's disease
$2,511,117Priyanka Narayan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Developing new tools for high throughput analysis of microcircuits and synapse ultrastructure using tagged vesicular transporters and deep learning.
$2,509,965Thomas Hnasko · University Of California, San Diego · RF1 · FY2019 · MH